Sonia Momin
Nurse Practitioner · Sugar Land, TXNPI 1164146536
Payments from drug & device makers
Across 70 payments — averaging $20.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$226
- AbbVie$206
- Novo Nordisk$171
- AstraZeneca$114
- Aimmune Therapeutics, Inc.$113
- Amgen$100
- plus $490 from 14 others
What the payments were for
- Food & beverage$1,420100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 10 | $226 |
| AbbVie | 8 | $206 |
| Novo Nordisk | 9 | $171 |
| AstraZeneca | 6 | $114 |
| Aimmune Therapeutics, Inc. | 6 | $113 |
| Amgen | 6 | $100 |
| Nestle Healthcare Nutrition Inc. | 5 | $97 |
| Bayer | 4 | $72 |
| Pfizer | 3 | $61 |
| Shield Therapeutics Inc | 2 | $43 |
| Merck | 2 | $35 |
| Seqirus USA Inc | 1 | $27 |
| Boehringer Ingelheim | 1 | $26 |
| Sanofi-aventis U.S. LLC | 1 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Phathom Pharmaceuticals, Inc. | 1 | $21 |
| Phadia US Inc. | 1 | $16 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
How this compares
$1,420 in reported general payments places this provider in the 80th percentile of 5,422 nurse practitioner providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 22 | $21,856 |
| JanuviaSitagliptin Phosphate | 11 | $12,955 |
| JardianceEmpagliflozin | 12 | $9,664 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 40 | $943 |
| Atorvastatin Calcium | 78 | $716 |
| Fluticasone Propionate | 20 | $362 |
| Montelukast Sodium | 19 | $312 |
| Rosuvastatin Calcium | 14 | $302 |
| Amlodipine Besylate | 60 | $287 |
| Metformin Hcl | 48 | $270 |
| Losartan Potassium | 36 | $223 |
| Lisinopril | 63 | $196 |
| Omeprazole | 15 | $182 |
| Levothyroxine Sodium | 34 | $180 |
| Metoprolol Succinate | 16 | $172 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $171 | $21,85622 claims |
| MerckJanuvia | $35 | $12,95511 claims |
| Boehringer IngelheimJardiance | $26 | $9,66412 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 5,422 nurse practitioner providers in Texas.
Other nurse practitioner in Sugar Land
- Cecilia DavisAustin$262K
- Melanie MorrisHouston$254K
- Stephanie BrownHarlingen$235K
- Brittney MisercolaKilleen$223K
- Roger ChapmanTyler$211K
- Kelly BrassilHouston$194K
- Corrie BerkSan Antonio$155K
- Samantha OnealDallas$133K
- Monica WhiteLongview$118K
- Onna FeuchterSouthlake$108K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.